fda compounding semaglutide crackdown news today 2025 The is drawing a harder line on compounded weight loss drug marketing. In the May–June 2026 issue of Dispense Times, this article breaks down key violations cited in recent FDA enforcement The FDA is proposing the

These non-scale victories (NSVs) like better-fitting clothes, improved sleep, or reduced joint pain can be even more rewarding

How Tirzepatide Works: A Dual Receptor Agonist Tirzepatide operates by activating two key metabolic receptors : GLP-1 (Glucagon-Like Peptide-1) GIP (Gastric Inhibitory Polypeptide) Both hormones play essential roles in metabolism, influencing insulin secretion, appetite suppression, and weight loss

GLP-1s could contribute to eating disorder development and may help promote food restriction that allowed a person to maintain eating disorder behavior

Establish this eating pattern early because you will rely on it heavily during months two and three when side effects peak